Randy E. Wertheimer. Emergency Postcoital Contraception. „American Family Physician”, 2000-11-15. American Academy of Family Physicians. [dostęp 2006-07-23].brak numeru strony
I.M. Spitz, C.W. Bardin, L. Benton, A. Robbins. Early pregnancy termination with mifepristone and misoprostol in the United States. „N Engl J Med”. 338 (18), s. 1241–1247, 1998. DOI: 10.1056/NEJM199804303381801. PMID: 9562577.
EA. Schaff, SL. Fielding, SH. Eisinger, LS. Stadalius i inni. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. „Contraception”. 61 (1), s. 41-46, 2000. DOI: 10.1016/S0010-7824(99)00119-5. PMID: 10745068.
G. Piaggio i inni. Meta-analysis of randomized trials comparing different doses of mifepristone in emergency contraception. „Contraception”. 68 (6), s. 447–452, 2003. DOI: 10.1016/S0010-7824(03)00142-2. PMID: 14698075.
K. Gemzell-Danielsson, L. Marions. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. „Human Reproduction Update”. 10 (4), s. 341–348, 2004. DOI: 10.1093/humupd/dmh027. PMID: 15192056.
N. Chabbert-Buffet, G. Meduri, P. Bouchard, I.M. Spitz. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. „Hum Reprod Update”. 11 (3), s. 293–307, 2005. DOI: 10.1093/humupd/dmi002. PMID: 15790602.
C. Flexner. HIV drug development: the next 25 years. „Nat Rev Drug Discov”. 6 (12), s. 959-966, 2007. DOI: 10.1038/nrd2336. PMID: 17932493.
J.K. Belanoff, B.H. Flores, M. Kalezhan, B. Sund i inni. Rapid reversal of psychotic depression using mifepristone. „J Clin Psychopharmacol”. 21 (5), s. 516–521, 2001-10. DOI: 10.1097/00004714-200110000-00009. PMID: 11593077.
B.A. Lawton i inni. Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced abortion. „Contraception”. 73 (4), s. 431–432, 2006. DOI: 10.1016/j.contraception.2005.09.003. PMID: 16531180.
J. Steinauer, EA. Pritts, R. Jackson, AF. Jacoby. Systematic review of mifepristone for the treatment of uterine leiomyomata. „Obstet Gynecol”. 103 (6), s. 1331-6, Jun 2004. DOI: 10.1097/01.AOG.0000127622.63269.8b. PMID: 15172874.
IM. Spitz, SM. Grunberg, N. Chabbert-Buffet, T. Lindenberg i inni. Management of patients receiving long-term treatment with mifepristone. „Fertil Steril”. 84 (6), s. 1719-26, Dec 2005. DOI: 10.1016/j.fertnstert.2005.05.056. PMID: 16359971.
RP. Miech. Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii. „Ann Pharmacother”. 39 (9), s. 1483-1488, 2005. DOI: 10.1345/aph.1G189. PMID: 16046483.
C. Fiala, K. Gemzel-Danielsson. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. „Contraception”. 74 (1), s. 66–86, 2006. DOI: 10.1016/j.contraception.2006.03.018. PMID: 16781264.
O. Heikinheimo, R. Kekkonen, P. Lahteenmaki. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. „Contraception”. 68 (6), s. 421–426, 2003. DOI: 10.1016/S0010-7824(03)00077-5. PMID: 14698071.
S. Christin-Maitre, P. Bouchard, I.M. Spitz. Medical termination of pregnancy. „N Engl J Med”. 342 (13), s. 946–956, 2000. DOI: 10.1056/NEJM200003303421307. PMID: 10738054.
B. Ganatra, M. Bygdeman, D.V. Nguyen, M.L. Vu i inni. From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam. „Reprod Health Matters”. 12 (24), s. 105–113, 2004. DOI: 10.1016/S0968-8080(04)24022-8. PMID: 15938163.
Ricardo H.R.H.AschRicardo H.R.H. i inni, Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486, „Human Reproduction”, 5 (4), 1990, s. 481-483, DOI: 10.1093/oxfordjournals.humrep.a137128, PMID: 2362012.
C.C.LelaidierC.C., C.C.Baton-Saint-MleuxC.C., H.H.FernandezH.H., P.P.BourgetP.P., R.R.FrydmanR.R., Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial, „Human Reproduction”, 8 (3), 1993, s. 492-495, DOI: 10.1093/oxfordjournals.humrep.a138078, PMID: 8473474
D.D.CabrolD.D., C.C.DuboisC.C., H.H.CronjeH.H., JM.J.GonnetJM.J., M.M.GuillotM.M., Induction of labor with mifepristone (RU 486) in intrauterine fetal death, „American journal of obstetrics and gynecology”, 163 (2), 1990, s. 540-542, DOI: 10.1016/0002-9378(90)91193-g, PMID: 2201190.
K.K.ClarkK.K. i inni, Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events, „American Journal of Obstetrics and Gynecology”, 5, 194, 2006, s. 1391–1398, DOI: 10.1016/j.ajog.2005.11.026, PMID: 16647925.
E.E.E.E.BaulieuE.E.E.E., D.S.D.S.SeidmanD.S.D.S., S.S.HajriS.S., Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations or anecdotal religion-based attitudes?, „Human Reproduction (Oxford, England)”, 16 (10), 2001, s. 2243–2244, DOI: 10.1093/humrep/16.10.2243, ISSN0268-1161, PMID: 11574524 [dostęp 2022-08-27].
WalterW.HerrmannWalterW. i inni, [The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy], „Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie”, 18, 294, 1982, s. 933–938, PMID: 6814714(fr.)
W. Smith. Great Britain second country to allow use of RU-486. „Plan Parent Eur”. 20 (2), 1991. PMID: 12284548.
RU 486 licensed in Sweden. „IPPF Med Bull”. 26 (6), 1992. PMID: 12346922.
I.M. Spitz, C.W. Bardin, L. Benton, A. Robbins. Early pregnancy termination with mifepristone and misoprostol in the United States. „N Engl J Med”. 338 (18), s. 1241–1247, 1998. DOI: 10.1056/NEJM199804303381801. PMID: 9562577.
EA. Schaff, SL. Fielding, SH. Eisinger, LS. Stadalius i inni. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. „Contraception”. 61 (1), s. 41-46, 2000. DOI: 10.1016/S0010-7824(99)00119-5. PMID: 10745068.
Ricardo H.R.H.AschRicardo H.R.H. i inni, Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486, „Human Reproduction”, 5 (4), 1990, s. 481-483, DOI: 10.1093/oxfordjournals.humrep.a137128, PMID: 2362012.
C.C.LelaidierC.C., C.C.Baton-Saint-MleuxC.C., H.H.FernandezH.H., P.P.BourgetP.P., R.R.FrydmanR.R., Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial, „Human Reproduction”, 8 (3), 1993, s. 492-495, DOI: 10.1093/oxfordjournals.humrep.a138078, PMID: 8473474
D.D.CabrolD.D., C.C.DuboisC.C., H.H.CronjeH.H., JM.J.GonnetJM.J., M.M.GuillotM.M., Induction of labor with mifepristone (RU 486) in intrauterine fetal death, „American journal of obstetrics and gynecology”, 163 (2), 1990, s. 540-542, DOI: 10.1016/0002-9378(90)91193-g, PMID: 2201190.
S. Nielsen, M. Hahlin, J. Platz-Christensen. Randomised trial comparing expectant with medical management for first trimester miscarriages. „Br J Obstet Gynaecol”. 106 (8), s. 804-807, 1999. PMID: 10453830.
G. Piaggio i inni. Meta-analysis of randomized trials comparing different doses of mifepristone in emergency contraception. „Contraception”. 68 (6), s. 447–452, 2003. DOI: 10.1016/S0010-7824(03)00142-2. PMID: 14698075.
K. Gemzell-Danielsson, L. Marions. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. „Human Reproduction Update”. 10 (4), s. 341–348, 2004. DOI: 10.1093/humupd/dmh027. PMID: 15192056.
N. Chabbert-Buffet, G. Meduri, P. Bouchard, I.M. Spitz. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. „Hum Reprod Update”. 11 (3), s. 293–307, 2005. DOI: 10.1093/humupd/dmi002. PMID: 15790602.
C. Flexner. HIV drug development: the next 25 years. „Nat Rev Drug Discov”. 6 (12), s. 959-966, 2007. DOI: 10.1038/nrd2336. PMID: 17932493.
J.K. Belanoff, B.H. Flores, M. Kalezhan, B. Sund i inni. Rapid reversal of psychotic depression using mifepristone. „J Clin Psychopharmacol”. 21 (5), s. 516–521, 2001-10. DOI: 10.1097/00004714-200110000-00009. PMID: 11593077.
B.A. Lawton i inni. Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced abortion. „Contraception”. 73 (4), s. 431–432, 2006. DOI: 10.1016/j.contraception.2005.09.003. PMID: 16531180.
J. Steinauer, EA. Pritts, R. Jackson, AF. Jacoby. Systematic review of mifepristone for the treatment of uterine leiomyomata. „Obstet Gynecol”. 103 (6), s. 1331-6, Jun 2004. DOI: 10.1097/01.AOG.0000127622.63269.8b. PMID: 15172874.
IM. Spitz, SM. Grunberg, N. Chabbert-Buffet, T. Lindenberg i inni. Management of patients receiving long-term treatment with mifepristone. „Fertil Steril”. 84 (6), s. 1719-26, Dec 2005. DOI: 10.1016/j.fertnstert.2005.05.056. PMID: 16359971.
RP. Miech. Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii. „Ann Pharmacother”. 39 (9), s. 1483-1488, 2005. DOI: 10.1345/aph.1G189. PMID: 16046483.
C. Fiala, K. Gemzel-Danielsson. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. „Contraception”. 74 (1), s. 66–86, 2006. DOI: 10.1016/j.contraception.2006.03.018. PMID: 16781264.
O. Heikinheimo, R. Kekkonen, P. Lahteenmaki. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. „Contraception”. 68 (6), s. 421–426, 2003. DOI: 10.1016/S0010-7824(03)00077-5. PMID: 14698071.
K.K.ClarkK.K. i inni, Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events, „American Journal of Obstetrics and Gynecology”, 5, 194, 2006, s. 1391–1398, DOI: 10.1016/j.ajog.2005.11.026, PMID: 16647925.
S. Christin-Maitre, P. Bouchard, I.M. Spitz. Medical termination of pregnancy. „N Engl J Med”. 342 (13), s. 946–956, 2000. DOI: 10.1056/NEJM200003303421307. PMID: 10738054.
A. Ulmann. The development of mifepristone: a pharmaceutical drama in three acts. „J Am Med Women's Assoc”. 55 (3 Suppl), s. 117–120, 2000. PMID: 10846319.
S. Wu. Medical abortion in China. „J Am Med Women's Assoc”. 55 (3 Suppl), s. 197–199, 204, 2000. PMID: 10846339.
E.M. Tsai, C.H. Yang, J.N. Lee. Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women. „J Formos Med Assoc”. 101 (4), s. 277–282, 2002. PMID: 12101864.
B. Ganatra, M. Bygdeman, D.V. Nguyen, M.L. Vu i inni. From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam. „Reprod Health Matters”. 12 (24), s. 105–113, 2004. DOI: 10.1016/S0968-8080(04)24022-8. PMID: 15938163.
WalterW.HerrmannWalterW. i inni, [The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy], „Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie”, 18, 294, 1982, s. 933–938, PMID: 6814714(fr.)